title: Penicillin allergy skin testing: what do we do now?
abstract: Drug-induced anaphylaxis remains a relatively infrequent event. However, penicillin and associated beta-lactam antibiotics remain a primary cause of anaphylaxis. Penicillin allergies are undoubtedly overreported, and patients with suspected penicillin allergy can be treated with antibiotic alternatives. Penicillin allergy skin testing is a simple and effective way to identify true penicillin allergy. Skin testing involves testing for both major and minor determinants and should be conducted in a facility with available life-support equipment. The commercial major determinant product, benzylpenicilloyl-polylysine, was removed from the market in 2004; this action compromised the ability of clinicians to evaluate a patient's likely response to penicillin therapy. Alternatives to skin testing include laboratory synthesis of major determinants, use of the radioallergosorbent test (RAST), or a combination of RAST and minor determinant skin testing. Patients with suspected penicillin allergy can undergo desensitization if they require penicillin therapy. The planned return of a commercial major determinant will hopefully resolve this issue.
authors: College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA.
authors: Jeremy A
authors: JA
authors: Schafer
authors: Noe
authors: N
authors: Mateo
authors: Garry L
authors: GL
authors: Parlier
authors: John C
authors: JC
authors: Rotschafer
mesh_terms: D003888:Desensitization, Immunologic / Q000379:methods; D004342:Drug Hypersensitivity / Q000175:diagnosis*; D006801:Humans; D010406:Penicillins / Q000009:adverse effects*; D011852:Radioallergosorbent Test / Q000379:methods; D012882:Skin Tests / Q000379:methods*
chemical_list: D010406:Penicillins